alvelestat   Click here for help

GtoPdb Ligand ID: 6476

Synonyms: AZD 9668 | AZD-9668 | AZD9668 | KB-105160
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: AZD9668 is a potent, selective and reversible inhibitor of human neutrophil elastase. It was developed as having the potential to be effective for neutrophil-driven inflammatory lung diseases, such as bronchiectasis and COPD [2]. Since the phase II studies did not show clear efficacy for COPD this compound is now listed in the AstraZeneca Open Innovation Clinical Compound Bank for repurposing proposals.

There is ambiguity on PubChem in the assigned nomenclature and stuctures for this compound, as CID 71587812 has been incorrectly assigned alvelestat as a synonym.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 123.81
Molecular weight 545.13
XLogP 4.52
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(c1cc(c(n(c1=O)c1cccc(c1)C(F)(F)F)C)c1ccnn1C)NCc1ccc(cn1)S(=O)(=O)C
Isomeric SMILES O=C(c1cc(c(n(c1=O)c1cccc(c1)C(F)(F)F)C)c1ccnn1C)NCc1ccc(cn1)S(=O)(=O)C
InChI InChI=1S/C25H22F3N5O4S/c1-15-20(22-9-10-31-32(22)2)12-21(23(34)30-13-17-7-8-19(14-29-17)38(3,36)37)24(35)33(15)18-6-4-5-16(11-18)25(26,27)28/h4-12,14H,13H2,1-3H3,(H,30,34)
Immunopharmacology Disease
Disease X-Refs Comment References
Graft versus host disease A Phase 2 clinical candidate for bronchiolitis obliterans syndrome resulting from chronic GVHD.
Chronic obstructive pulmonary disease Disease Ontology: DOID:3083
A Phase 2 clinical candidate for COPD.
Diabetes mellitus, noninsulin-dependent; NIDDM Disease Ontology: DOID:9352
OMIM: 125853
A Phase 2 clinical candidate predicted to exhibit a useful effect on T2D-associated inflammation.